Patents by Inventor Florence Arvis

Florence Arvis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CONCENTRATED HUMAN IMMUNOGLOBULIN COMPOSITION
    Publication number: 20160030563
    Abstract: A liquid pharmaceutical composition containing human immunoglobulin G, preferably at 230 g/l or higher. The composition, suitable for subcutaneous or intramuscular administration, can be used to treat various diseases, e.g., an antibody production defect and Kawasaki disease.
    Type: Application
    Filed: October 9, 2015
    Publication date: February 4, 2016
    Inventors: Sylvain Huille, Laetitia Cohen-Tannoudji, Florence Arvis, Alexandra Paillard
  • Concentrated human immunoglobulin composition
    Patent number: 9186401
    Abstract: The invention relates to a human immunoglobulin G composition characterized in that the human immunoglobulin G concentration is at least 230 g/l, which is of use in particular for subcutaneous administration.
    Type: Grant
    Filed: July 18, 2011
    Date of Patent: November 17, 2015
    Assignee: Laboratoire Francais Du Fractionnement Et Des Biotechnologies
    Inventors: Sylvain Huille, Laetitia Cohen-Tannoudji, Florence Arvis, Alexandra Paillard
  • SYRINGE CONTAINING A COMPOSITION, ESPECIALLY A PHARMACEUTICAL COMPOSITION, COMPRISING IMMUNOGLOBINS, METHOD FOR THE PRODUCTION THEREOF AND USE OF SAME
    Publication number: 20150224264
    Abstract: A syringe containing a composition, in particular pharmaceutical, including immunoglobulins, its manufacturing method and its use.
    Type: Application
    Filed: September 12, 2013
    Publication date: August 13, 2015
    Inventor: Florence Arvis
  • PHARMACEUTICAL COMPOSITION COMPRISING FACTOR VII ENCAPSULATED IN MICELLES
    Publication number: 20140220147
    Abstract: The invention relates to a pharmaceutical composition comprising factor VII encapsulated in micelles formed from block copolymer molecules containing (i) a hydrophilic polymer segment consisting of a polyalkylene glycol and (ii) a hydrophobic polymer segment consisting of a polyamino acid, with said polyamino acid comprising exclusively amino acid residues selected from the group consisting of histidine, lysine, aspartic acid and glutamic acid residues, wherein a part of said amino acid residues is substituted with a hydrophobic group.
    Type: Application
    Filed: July 31, 2012
    Publication date: August 7, 2014
    Applicants: NANOCARRIER, LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
    Inventors: Florence Arvis, Sylvain Huille, Mitsunori Harada
  • CONCENTRATED HUMAN IMMUNOGLOBULIN COMPOSITION
    Publication number: 20130121991
    Abstract: The invention relates to a human immunoglobulin G composition characterized in that the human immunoglobulin G concentration is at least 230 g/l, which is of use in particular for subcutaneous administration.
    Type: Application
    Filed: July 18, 2011
    Publication date: May 16, 2013
    Applicant: Laboratoire Francais Du Fractionnement Et Des Biotechnologies
    Inventors: Sylvain Huille, Laetitia Cohen-Tannoudji, Florence Arvis, Alexandra Paillard